Treatment of multidrug-resistant Pseudomonas aeruginosa infections: more attention required to in-vitro studies.

[1]  T. Tsaganos,et al.  Postantibiotic effect of antimicrobial combinations on multidrug-resistant Pseudomonas aeruginosa. , 2005, Diagnostic microbiology and infectious disease.

[2]  L. Aguilar,et al.  Is there a pharmacodynamic need for the use of continuous versus intermittent infusion with ceftazidime against Pseudomonas aeruginosa? An in vitro pharmacodynamic model. , 2005, The Journal of antimicrobial chemotherapy.

[3]  B. Iglewski,et al.  Azithromycin Retards Pseudomonas aeruginosa Biofilm Formation , 2004, Journal of Clinical Microbiology.

[4]  J. Handelsman,et al.  Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis. , 2004, The Lancet. Infectious diseases.

[5]  Leonard Leibovici,et al.  β lactam monotherapy versus β lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials , 2004, BMJ : British Medical Journal.

[6]  E. Giamarellos‐Bourboulis,et al.  Immunomodulatory Clarithromycin Treatment of Experimental Sepsis and Acute Pyelonephritis Caused by Multidrug-Resistant Pseudomonas aeruginosa , 2004, Antimicrobial Agents and Chemotherapy.

[7]  S. Oie,et al.  In vitro effects of combinations of antipseudomonal agents against seven strains of multidrug-resistant Pseudomonas aeruginosa. , 2003, The Journal of antimicrobial chemotherapy.

[8]  D. Paterson,et al.  Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  E. Giamarellos‐Bourboulis,et al.  In Vitro Interaction of Colistin and Rifampin on Multidrug-Resistant Pseudomonas aeruginosa , 2003, Journal of chemotherapy.

[10]  A. Levin,et al.  Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  G. Rossolini,et al.  Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[12]  M. Badia,et al.  Use of colistin in the treatment of multiple-drug-resistant gram-negative infections. , 2005, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[13]  D. Livermore.  The need for new antibiotics. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.